Haematologica (Aug 2023)
Quantitative evaluation of the clinical severity of hemoglobin H disease in a cohort of 591 patients using a scoring system based on regression analysis
- Yumeng Liu,
- Yuan Zhuang,
- Jianhong Chen,
- Zeyan Zhong,
- Jianpei Fang,
- Xinyu Li,
- Bin Xiao,
- Pingping Li,
- Bin Lin,
- Zhenzhong Tao,
- Yidan Liang,
- Peng Lin,
- Xingmin Wang,
- Mengyang Song,
- Hualei Luo,
- Lang Qin,
- Li Huang,
- Jufang Tan,
- Hailiang Li,
- Tianyu Zhong,
- Lian Yu,
- Zhixiang Liu,
- Deguo Tang,
- Yongzhong Zhao,
- Xinhua Zhang,
- Yuhua Ye,
- Xiangmin Xu
Affiliations
- Yumeng Liu
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong
- Yuan Zhuang
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong
- Jianhong Chen
- Department of Medical Genetics and Prenatal Diagnosis, Huizhou First Maternal and Child Health Care Hospital, Huizhou, Guangdong, 516001
- Zeyan Zhong
- Department of Medical Genetics and Prenatal Diagnosis, Huizhou First Maternal and Child Health Care Hospital, Huizhou, Guangdong, 516001
- Jianpei Fang
- Department of Pediatric Hematology/Oncology, Children’s Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120
- Xinyu Li
- Department of Pediatric Hematology/Oncology, Children’s Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120
- Bin Xiao
- Department of Hematology, 923(rd) Hospital of the People's Liberation Army, Nanning, Guangxi 530021
- Pingping Li
- Department of Hematology, 923(rd) Hospital of the People's Liberation Army, Nanning, Guangxi 530021
- Bin Lin
- Guangzhou Huayin Healthcare Group Co., Ltd., Guangzhou 510663, Guangdong, China; Guangzhou Jiexu Gene Technology Co., Ltd., Guangzhou 510530, Guangdong
- Zhenzhong Tao
- Guangzhou Huayin Healthcare Group Co., Ltd., Guangzhou 510663, Guangdong, China; Guangzhou Jiexu Gene Technology Co., Ltd., Guangzhou 510530, Guangdong
- Yidan Liang
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong
- Peng Lin
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong
- Xingmin Wang
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong
- Mengyang Song
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong
- Hualei Luo
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong
- Lang Qin
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong
- Li Huang
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong
- Jufang Tan
- Prenatal Diagnosis Center, Chenzhou First People's Hospital Chenzhou 423000, Hunan
- Hailiang Li
- Department of Laboratory Hematology, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, Jiangxi
- Tianyu Zhong
- Department of Laboratory Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, Jiangxi
- Lian Yu
- Department of Hematology and Rheumatology, Longyan First Hospital, Affiliated to Fujian Medical University, Longyan 364000
- Zhixiang Liu
- Department of Medical Dispute, Maternal and Child Health Hospital, Heyuan517000
- Deguo Tang
- Maternal and Child Health Hospital of Yongzhou City, Yongzhou, Hunan 425000
- Yongzhong Zhao
- Biologics,Gene and Cell Therapy, Frontage Laboratories, 760 Pennsylvania Dr, Exton, PA, 19341
- Xinhua Zhang
- Department of Hematology, 923(rd) Hospital of the People's Liberation Army, Nanning, Guangxi 530021
- Yuhua Ye
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong
- Xiangmin Xu
- Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong
- DOI
- https://doi.org/10.3324/haematol.2023.283211
- Journal volume & issue
-
Vol. 109,
no. 2
Abstract
No abstracts available.
